BioCentury | May 18, 2020
Finance

$65M round positions SQZ Biotech for potential IPO, 2021 catalysts

SQZ Biotech is adding at least one experienced crossover investor to what could be its last private financing ahead of catalysts expected late this year and next. SQZ Biotechnologies Co. raised $65 million in a...
Items per page:
1 - 1 of 1